QuickLogic CEO to Moderate Panel on COVID-19 Screening Solution

SAN JOSE, Calif., Aug. 10, 2020 /PRNewswire/ — QuickLogic Corporation (NASDAQ: QUIK), a developer of ultra-low power multi-core voice-enabled SoCs, embedded FPGA IP, and Endpoint AI solutions, today announced that Brian Faith, CEO of QuickLogic, has been invited by ACG Silicon Valley (The Association for Corporate Growth in Silicon Valley) to moderate a panel discussion. The discussion is entitled “COVID-19 AI Screening Solutions – Protecting Those At-Risk During the Pandemic.”

Brian Faith of QuickLogic will be joined by Bryan Wisk, CIO of Asymmetric Return Capital, LLC, Mark Treat, Chief Strategy Officer at Upward Health, Chris Rogers, CEO of SensiML Corporation, Mike Ward, CEO of Linear ASICs Inc., Mark Litecky, CRO of SkyWater and Dr. Ali Imran, Founder of AI4LYF, LLC.

Please join our diverse panel as we explore the insights of this topical research. Real lives, perhaps those of your own family and friends, may depend on us getting the answers right.

Date:               Wednesday, August 12, 2020

Time:               9:00 – 10:00 a.m., Pacific Time

Register:          http://acgsv.org/event/covid-19-ai-screening-solutions/    

About QuickLogic
QuickLogic Corporation (NASDAQ: QUIK) is a fabless semiconductor company that develops low power, multi-core semiconductor platforms and Intellectual Property (IP) for Artificial Intelligence (AI), voice and sensor processing. The solutions include embedded FPGA IP (eFPGA) for hardware acceleration and pre- processing, and heterogeneous multi-core SoCs that integrate eFPGA with other processors and peripherals. The Analytics Toolkit from our recently acquired wholly-owned subsidiary, SensiML Corporation, completes the end-to-end solution with accurate sensor algorithms using AI technology. The full range of platforms, software tools and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across mobile, wearable, hearable, consumer, industrial, edge and endpoint IoT. For more information, visit www.quicklogic.com and http://www.quicklogic.com/blog.

QuickLogic and logo are registered trademarks of QuickLogic. All other trademarks are the property of their respective holders and should be treated as such.

View original content to download multimedia:http://www.prnewswire.com/news-releases/quicklogic-ceo-to-moderate-panel-on-covid-19-screening-solution-301108892.html

SOURCE QuickLogic Corporation

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

25 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

14 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

17 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

17 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

17 hours ago